Author

Paraj Patel

Institution: Medical College of Wisconsin

Observed institutions: Pfizer (United States), Medical College of Wisconsin, Milwaukee VA Medical Center

ORCID: 0009-0009-7017-0519

Observed ORCID: 0009-0009-7017-0519

OpenAlex ID: A5114019231

In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels

2017 · Jonathan J. Cherry, Christine J. DiDonato, et al. · PLoS ONE · 18

Impact of Adenosine Diphosphate and Calcium Chelation on Platelet Aggregation Testing in Patients Receiving Clopidogrel Therapy

2006 · Paraj Patel, Rafael Gonzales, et al. · Journal of the American College of Cardiology · 14

S1073 Inflammatory Bowel Disease is Associated With Increased Risk of Cardiovascular Events but Not Mortality. Data From a Large U.S. National Database

2024 · Saffia Bajwa, Paraj Patel, et al. · The American Journal of Gastroenterology · 1

718 Biologics and Jak Inhibitors Decrease Major Cardiovascular Events (mace) in Ibd Patients. Data From a Large National Cohort. Is It the Mechanism of the Drug or Control of Disease?

2024 · Paraj Patel, Omair Iqbal, et al. · Gastroenterology · 1

S998 Validation of ICD-10-CM Diagnosis Codes in Patients With Inflammatory Bowel Disease in the National Veterans Affairs Healthcare System

2023 · Paraj Patel, Katherine Sherman, et al. · The American Journal of Gastroenterology · 1

S3005 A Rare Case of Double Pylorus in an Elderly Woman

2023 · Chanelle Chua, Harpreet Singh, et al. · The American Journal of Gastroenterology · 1

Editorial commentary: Unraveling the mechanistic link between atherosclerosis and inflammatory bowel disease. Can we find a target?

2023 · Paraj Patel, Preetika Sinh · Trends in Cardiovascular Medicine · 1

S3570 Clinical and Pathologic Response to Vedolizumab in a Young Female Patient With Collagenous Gastritis

2022 · Paraj Patel, Saryn Doucette, et al. · The American Journal of Gastroenterology · 1

Safety of biologics and Janus kinase inhibitors in inflammatory bowel disease patients with low cardiovascular risk

2026 · Paraj Patel, Omair Iqbal, et al. · Crohn s & Colitis 360

S1653 Cardiovascular Risk Factors Drive Mortality in Patients With Inflammatory Bowel Disease—A Propensity-Matched US National Database Study

2025 · Paraj Patel, Omar Iqbal, et al. · The American Journal of Gastroenterology

Mo1898: INCREASED RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS PRIMARILY DRIVEN BY PRESENCE OF CARDIOVASCULAR RISK FACTORS AND PRIOR CORONARY ARTERY DISEASE.

2025 · Paraj Patel, Omair Iqbal, et al. · Gastroenterology

Mo1806 ANTI TNF MEDICATIONS BUT NOT JAK INHIBITORS ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM. DATA FROM A LARGE NATIONAL COHORT. IS IT THE MECHANISM OF THE DRUG OR THE DISEASE?

2024 · Omair Iqbal, Paraj Patel, et al. · Gastroenterology

S116 Validation of an Automated Data Collection Method of Inflammatory Bowel Disease Medications in the National Veterans Affairs Healthcare System

2023 · Saffia Bajwa, Preetika Sinh, et al. · The American Journal of Gastroenterology

S1226 Impact of Fellowship Training Level on Quality Metrics in Veterans Undergoing Screening Colonoscopy

2020 · Bao Chau Nguyen, Paraj Patel, et al. · The American Journal of Gastroenterology

Works count: 14

Citation count: 38

H-index: 2

I10-index: 2